Advertisement
Screener

Decoy Therapeutics Inc. (DCOY) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

2.2 / 5 stars · 36/82 Roast Me

Decoy Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

Decoy Therapeutics Inc. (DCOY) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-12

  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares.
  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares.
  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 0.00 shares, a 100.00% decline from fiscal 2024.
  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 117.00 shares.
  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 0.00 shares, a 100.00% decline from fiscal 2022.
  • Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 51.36K shares, a 1525.32% increase from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, GrossShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 10 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed
2026-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
0.00 shares
10-Q · filed 2026-08-12
0.00 shares
derived: sum of 3 quarters · filed 2026-08-12
0.00 shares
derived: sum of 4 quarters · filed 2026-08-12
2026-03-310.00 shares
10-Q · filed 2026-05-08
0.00 shares
derived: sum of 2 quarters · filed 2026-05-08
0.00 shares
derived: sum of 3 quarters · filed 2026-05-08
0.00 shares
derived: sum of 4 quarters · filed 2026-08-12
2025-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
0.00 shares
derived: sum of 2 quarters · filed 2026-03-31
0.00 shares
derived: sum of 3 quarters · filed 2026-08-12
0.00 shares
10-K · filed 2026-03-31
2025-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
0.00 shares
derived: sum of 2 quarters · filed 2026-08-12
0.00 shares
10-Q · filed 2025-11-14
-1.29K shares
derived: sum of 4 quarters · filed 2026-08-12
2025-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
0.00 shares
10-Q · filed 2026-08-12
-1.29K shares
derived: sum of 3 quarters · filed 2026-08-12
-21.01K shares
derived: sum of 4 quarters · filed 2026-08-12
2025-03-310.00 shares
10-Q · filed 2026-05-08
-1.29K shares
derived: sum of 2 quarters · filed 2026-05-08
-21.01K shares
derived: sum of 3 quarters · filed 2026-05-08
-18.45K shares
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31-1.29K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
-21.01K shares
derived: sum of 2 quarters · filed 2026-03-31
-18.45K shares
derived: sum of 3 quarters · filed 2026-03-31
117.00 shares
10-K · filed 2026-03-31
21.13K shares
10-K · filed 2025-03-21
2024-09-30-19.72K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
-17.16K shares
derived: sum of 2 quarters · filed 2025-11-14
1.41K shares
10-Q · filed 2025-11-14
21.13K shares
10-Q · filed 2024-11-14
1.41K shares
derived: sum of 4 quarters · filed 2025-11-14
2024-06-302.56K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
21.13K shares
10-Q · filed 2025-08-12
21.13K shares
derived: sum of 3 quarters · filed 2025-08-12
21.13K shares
derived: sum of 4 quarters · filed 2025-08-12
2024-03-3118.57K shares
10-Q · filed 2025-05-14
148.50K shares
10-Q · filed 2024-05-13
18.57K shares
derived: sum of 2 quarters · filed 2025-05-14
18.57K shares
derived: sum of 3 quarters · filed 2025-05-14
18.57K shares
derived: sum of 4 quarters · filed 2025-05-14
2023-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21
0.00 shares
derived: sum of 2 quarters · filed 2025-03-21
0.00 shares
derived: sum of 3 quarters · filed 2025-03-21
0.00 shares
10-K · filed 2025-03-21
2023-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
0.00 shares
derived: sum of 2 quarters · filed 2024-11-14
0.00 shares
10-Q · filed 2024-11-14
0.00 shares
derived: sum of 4 quarters · filed 2024-11-14
2023-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
0.00 shares
10-Q · filed 2024-08-09
0.00 shares
derived: sum of 3 quarters · filed 2024-08-09
0.00 shares
derived: sum of 4 quarters · filed 2024-08-09
2023-03-310.00 shares
10-Q · filed 2024-05-13
0.00 shares
derived: sum of 2 quarters · filed 2024-05-13
0.00 shares
derived: sum of 3 quarters · filed 2024-05-13
1.20K shares
derived: sum of 4 quarters · filed 2024-05-13
2022-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22
0.00 shares
derived: sum of 2 quarters · filed 2024-03-22
1.20K shares
derived: sum of 3 quarters · filed 2024-03-22
51.36K shares
10-K · filed 2024-03-22
2022-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
1.20K shares
derived: sum of 2 quarters · filed 2023-11-09
51.36K shares
10-Q · filed 2023-11-09
51.36K shares
derived: sum of 4 quarters · filed 2023-11-09
2022-06-301.20K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
51.36K shares
10-Q · filed 2023-08-10
1.28M shares
10-Q · filed 2022-08-05
51.36K shares
derived: sum of 3 quarters · filed 2023-08-10
-13.98K shares
derived: sum of 4 quarters · filed 2023-08-10
2022-03-3150.16K shares
10-Q · filed 2023-05-11
1.25M shares
10-Q · filed 2022-05-12
50.16K shares
derived: sum of 2 quarters · filed 2023-05-11
-15.18K shares
derived: sum of 3 quarters · filed 2023-05-11
13.32K shares
derived: sum of 4 quarters · filed 2023-05-11
2021-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27
-65.34K shares
derived: sum of 2 quarters · filed 2023-03-27
-36.84K shares
derived: sum of 3 quarters · filed 2023-03-27
3.16K shares
10-K · filed 2023-03-27
79.00K shares
10-K · filed 2022-03-25
2021-09-30-65.34K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
-36.84K shares
derived: sum of 2 quarters · filed 2022-11-10
3.16K shares
10-Q · filed 2022-11-10
79.00K shares
10-Q · filed 2021-11-04
728.16K shares
derived: sum of 4 quarters · filed 2022-11-10
2021-06-3028.50K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05
68.50K shares
10-Q · filed 2022-08-05
793.50K shares
derived: sum of 3 quarters · filed 2022-08-05
1.35M shares
derived: sum of 4 quarters · filed 2022-08-05
2021-03-3140.00K shares
10-Q · filed 2022-05-12
765.00K shares
derived: sum of 2 quarters · filed 2022-05-12
1.33M shares
derived: sum of 3 quarters · filed 2022-05-12
1.33M shares
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31725.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25
1.29M shares
derived: sum of 2 quarters · filed 2022-03-25
1.29M shares
derived: sum of 3 quarters · filed 2022-03-25
1.47M shares
10-K · filed 2022-03-25
2020-09-30561.12K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
561.12K shares
derived: sum of 2 quarters · filed 2021-11-04
743.12K shares
10-Q · filed 2021-11-04
743.12K shares
derived: sum of 4 quarters · filed 2021-11-04
2020-09-1620.00K shares
10-Q · filed 2020-11-12
2020-07-14541.12K shares
10-Q · filed 2020-11-12
2020-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
182.00K shares
10-Q · filed 2021-08-05
182.00K shares
derived: sum of 3 quarters · filed 2021-08-05
283.08K shares
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31182.00K shares
10-Q · filed 2021-05-12
182.00K shares
derived: sum of 2 quarters · filed 2021-05-12
283.08K shares
derived: sum of 3 quarters · filed 2021-05-12
283.08K shares
derived: sum of 4 quarters · filed 2021-05-12
2020-03-23182.00K shares
10-Q · filed 2020-11-12
2019-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18
101.08K shares
derived: sum of 2 quarters · filed 2021-03-18
101.08K shares
derived: sum of 3 quarters · filed 2021-03-18
101.08K shares
10-K · filed 2021-03-18
2019-09-30101.08K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
101.08K shares
derived: sum of 2 quarters · filed 2019-11-12
101.08K shares
10-Q · filed 2019-11-12
101.08K shares
derived: sum of 4 quarters · filed 2019-11-12
2019-09-10101.08K shares
10-K · filed 2021-03-18
2019-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-17
0.00 shares
10-Q · filed 2019-07-17
0.00 shares
derived: sum of 3 quarters · filed 2019-07-17
50.00K shares
derived: sum of 4 quarters · filed 2019-07-17
2019-03-310.00 shares
10-Q · filed 2019-05-01
0.00 shares
derived: sum of 2 quarters · filed 2019-05-01
50.00K shares
derived: sum of 3 quarters · filed 2019-05-01
704.54K shares
derived: sum of 4 quarters · filed 2019-05-01
2018-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06
50.00K shares
derived: sum of 2 quarters · filed 2019-03-06
704.54K shares
derived: sum of 3 quarters · filed 2019-03-06
1.52M shares
10-K · filed 2019-03-06
2018-09-3050.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05
704.54K shares
derived: sum of 2 quarters · filed 2018-11-05
1.52M shares
10-Q · filed 2018-11-05
1.56M shares
derived: sum of 4 quarters · filed 2019-03-06
2018-06-30654.54K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01
1.47M shares
10-Q · filed 2018-08-01
1.51M shares
derived: sum of 3 quarters · filed 2019-03-06
1.73M shares
derived: sum of 4 quarters · filed 2019-03-06
2018-06-14654.54K shares
10-Q · filed 2019-07-17
2018-03-31813.00K shares
10-Q · filed 2018-05-02
854.00K shares
derived: sum of 2 quarters · filed 2019-03-06
1.08M shares
derived: sum of 3 quarters · filed 2019-03-06
1.28M shares
derived: sum of 4 quarters · filed 2019-03-06
2017-12-3141.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06
267.00K shares
derived: sum of 2 quarters · filed 2019-03-06
472.00K shares
derived: sum of 3 quarters · filed 2019-03-06
1.06M shares
10-K · filed 2019-03-06
2017-09-30226.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06
431.00K shares
derived: sum of 2 quarters · filed 2017-11-06
1.02M shares
10-Q · filed 2017-11-06
1.02M shares
derived: sum of 4 quarters · filed 2019-03-06
2017-06-30205.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
792.50K shares
10-Q · filed 2017-08-02
796.00K shares
derived: sum of 3 quarters · filed 2019-03-06
856.00K shares
derived: sum of 4 quarters · filed 2019-03-06
2017-03-31587.50K shares
10-Q · filed 2017-05-03
591.00K shares
derived: sum of 2 quarters · filed 2019-03-06
651.00K shares
derived: sum of 3 quarters · filed 2019-03-06
784.17K shares
derived: sum of 4 quarters · filed 2019-03-06
2016-12-313.50K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06
63.50K shares
derived: sum of 2 quarters · filed 2019-03-06
196.67K shares
derived: sum of 3 quarters · filed 2019-03-06
763.32K shares
10-K · filed 2019-03-06
2016-09-3060.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
193.17K shares
derived: sum of 2 quarters · filed 2016-11-02
759.82K shares
10-Q · filed 2016-11-02
1.25M shares
derived: sum of 4 quarters · filed 2018-03-07
2016-06-30133.17K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03
699.82K shares
10-Q · filed 2016-08-03
1.19M shares
derived: sum of 3 quarters · filed 2018-03-07
1.19M shares
derived: sum of 4 quarters · filed 2018-03-07
2016-03-31566.65K shares
10-Q · filed 2016-05-04
1.06M shares
derived: sum of 2 quarters · filed 2018-03-07
1.06M shares
derived: sum of 3 quarters · filed 2018-03-07
1.27M shares
derived: sum of 4 quarters · filed 2018-03-07
2015-12-31489.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07
489.00K shares
derived: sum of 2 quarters · filed 2018-03-07
707.00K shares
derived: sum of 3 quarters · filed 2018-03-07
994.75K shares
10-K · filed 2018-03-07
2015-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04
218.00K shares
derived: sum of 2 quarters · filed 2015-11-04
505.75K shares
10-Q · filed 2015-11-04
2015-06-30218.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05
505.75K shares
10-Q · filed 2015-08-05
2015-03-31287.74K shares
10-Q · filed 2015-05-06
2014-12-311.02M shares
10-K · filed 2017-03-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nexentis Technologies Inc. (NXTS)$0.002B
ORAGENICS INC (OGEN)United States$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Protagenic Therapeutics, Inc.\new (PTIX)United States$0.001B
Silo Pharma, Inc. (SILO)United States$0.003B-1.57